Expertise in
7
conditions

Franck Durif

Clermont-ferrand, FR 
Clinical Trials:Currently Recruiting for 2 Trials
Expertise in
7
conditions
Clermont-ferrand, FR 

Overview

Franck Durif practices practicing medicine in Clermont-ferrand, France.

Mr. Durif is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Parkinson's Disease, Movement Disorders, Drug Induced Dyskinesia, Deep Brain Stimulation, and Sacral Nerve Stimulation.

He is actively involved in clinical research, co-authoring 122 peer reviewed articles and participating in 13 clinical trials.

Gender

Male

Locations

Clermont-ferrand, France
Other Locations
Strasbourg, France
Marseille, France
Bâtiment Babinski, Consultation De Pathologie Neuro Musculaire, 47, Boulevard De L'Hôpital, 75651 Paris Cedex 13, Paris, 75651, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

13 Clinical Trials

Exploration of Differences in Metabolite Concentrations by 7Teslas NMR Spectroscopy in Striatum and Subthalamic Nuclei in de Novo Parkinsonian Patients and Control Subjects
Exploration of Differences in Metabolite Concentrations by 7Teslas NMR Spectroscopy in Striatum and Subthalamic Nuclei in de Novo Parkinsonian Patients and Control Subjects
Enrollment Status: Recruiting
Publish Date: February 27, 2026
Intervention Type: Other
Study Phase: Not Applicable
Abbott DBS Post-Market Study of Outcomes for Indications Over Time
Abbott DBS Post-Market Study of Outcomes for Indications Over Time
Enrollment Status: Recruiting
Publish Date: January 08, 2026
Intervention Type: Device
Impact of Amantadine on L-DOPA-induced Dyskinesia in Early Parkinson's Disease: a Placebo-controlled Randomized Study (the PREMANDYSK Study)
Impact of Amantadine on L-DOPA-induced Dyskinesia in Early Parkinson's Disease: a Placebo-controlled Randomized Study (the PREMANDYSK Study)
Enrollment Status: Completed
Publish Date: April 06, 2026
Intervention Type: Drug
Study Phase: Phase 2
Study of Pimavanserin Efficacy for the Treatment of Impulse Control Disorders in Parkinson's Disease
Study of Pimavanserin Efficacy for the Treatment of Impulse Control Disorders in Parkinson's Disease
Enrollment Status: Completed
Publish Date: March 16, 2026
Intervention Type: Drug, Procedure, Behavioral
Study Drug: Pimavanserin
Study Phase: Phase 2
French Validation Study of a New Scale for Neuropsychiatric Fluctuations in Parkinson Disease
French Validation Study of a New Scale for Neuropsychiatric Fluctuations in Parkinson Disease
Enrollment Status: Completed
Publish Date: December 22, 2025
Intervention Type: Other
Study Phase: Not Applicable
Study of Efficacy and Acceptability of Tetrabenazine in the Late Dyskinetic Syndrome With Neuroleptics: A Randomized, Parallel Group, Double-blind Placebo Controlled Multicentre Trial
Study of Efficacy and Acceptability of Tetrabenazine in the Late Dyskinetic Syndrome With Neuroleptics: A Randomized, Parallel Group, Double-blind Placebo Controlled Multicentre Trial
Enrollment Status: Completed
Publish Date: November 19, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Dose-Ranging Study of the Efficacy, Safety, and Pharmacokinetics of Deferiprone Delayed Release Tablets in Patients With Parkinson's Disease
A Dose-Ranging Study of the Efficacy, Safety, and Pharmacokinetics of Deferiprone Delayed Release Tablets in Patients With Parkinson's Disease
Enrollment Status: Completed
Publish Date: April 10, 2024
Intervention Type: Drug
Study Phase: Phase 2
Circadian Character of Food Compulsions and Impulses Control Disorders in Parkinsonian Patients With and Without Resting Leg Syndrome
Circadian Character of Food Compulsions and Impulses Control Disorders in Parkinsonian Patients With and Without Resting Leg Syndrome
Enrollment Status: Completed
Publish Date: July 10, 2023
Intervention Type: Behavioral
Study Phase: Not Applicable
Evaluation of Botulinum Toxin Injection Efficacy in the Treatment of Head Essential Tremor by a Multi-center, Randomized, Double-Blind, Parallel-group, Placebo-controlled Study
Evaluation of Botulinum Toxin Injection Efficacy in the Treatment of Head Essential Tremor by a Multi-center, Randomized, Double-Blind, Parallel-group, Placebo-controlled Study
Enrollment Status: Completed
Publish Date: December 12, 2022
Intervention Type: Drug
Study Drug: BOTOX
Study Phase: Phase 3
Predictive Factors for Therapeutic Response of Subthalamic Stimulation on Quality of Live in Parkinson's Disease
Predictive Factors for Therapeutic Response of Subthalamic Stimulation on Quality of Live in Parkinson's Disease
Enrollment Status: Unknown
Publish Date: November 07, 2022
Intervention Type: Other
View 8 Less Clinical Trials

122 Total Publications

Disease Progression in Multiple System Atrophy: The ASPIRE Multi-Modal Biomarker Study.
Disease Progression in Multiple System Atrophy: The ASPIRE Multi-Modal Biomarker Study.
Journal: Annals of neurology
Published: March 09, 2025

Frequently Asked Questions about Franck Durif

Is Franck Durif a top-rated expert for Parkinson's Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Franck Durif is classified as an Elite expert for Parkinson's Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Franck Durif participate in research or clinical trials?

Yes. Franck Durif has published 122 articles and abstracts on conditions like Parkinson's Disease. You can view a list of Franck Durif's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Durif's expertise for a condition
ConditionClose
View All 14 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile